KVK Research Pleads Guilty To Adulterated Drug Distribution
The Generics Manufacturer Will Pay A Total Of $3.5m, Including Civil Liability Resolution
Executive Summary
KVK Research and KVK Tech failed to notify the US FDA about the use of a foreign API manufacturing facility and submitted alleged false claims to governmental health programs.